Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Law & Regulation Reference Listed Drug (RLD) Marketing Approval Bioequivalence (BE) Drug RegistrationCPhI & BaiPharm Event: Generic Drug Application Procedures in China On June 22, BaiPharm is going to co-organize a webinar with CPhI China on the topic of Generic Drug Application Procedures in China.
Jun 21, 2022
Law & Regulation Pharmacopoeia MAH Pharmacovigilance Marketing Approval Innovative Drug Drug Registration New DrugCRAC-HCF 2021 | Embracing China's Pharma Market With Regulatory Compliance and Industry Insights Five experts from drug regulation authorities, pharmaceutical companies, and consulting firms decoded drug regulations and analyzed industry dynamics for international pharma companies to develop businesses in the Chinese market.
Nov 17, 2021
NMPA-Approved Injectable Fillers in China's Market China’s promising injectable filler market is expected to witness other new products' emergence. The market size is predicted to grow from US$ 603.8 million in 2019 to US$ 1,063.53 million by 2026. Meanwhile, China tightens the regulation on aesthetic medical products or practices so injectable fillers and relevant businesses won’t be an exception.
Nov 04, 2021
Law & Regulation Pharmacopoeia MAH Pharmacovigilance Marketing Approval Innovative Drug Drug Registration New DrugOnline Conference | China Drug Regulation and Pharmaceutical Market BaiPharm will hold a virtual conference on Nov. 12, as part of the CRAC-HCF 2021 event. We will have five speeches elaborating on China drug regulations and pharmaceutical market. The specific topics include China market entry strategy, Chinese Pharmacopoeia, GVP, MAH, and innovative drug research.
Oct 21, 2021
- China CDE Q&A | Drug Registration Applications & Clinical Trials
- How to Sell OTC Drugs to China via Cross-Border E-Commerce
- China's First Homegrown COVID-19 Pill, Azvudine, is Priced at 270 Yuan Per Bottle
- Monthly Report: New Drug Approvals in China | July 2022
- Monthly Report: New Drug Approvals in China | August 2022